The development and future of the NCRI
11 Nov 2011
The development and future of the NCRI
Cellular pathways in lung cancer and the need for personalised medicine
Understanding tumour metastasis
Toxicity and side effect prevention
Lifetime achievement award and future work
The tumour microenvironment
The TOR complex and inhibitor development
Modelling cancer genomes
Chromosome instability in cancer development
Increasing cancer survivorship with new check up procedures
Changes in breast cancer management
RAPPER: Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy